Document
IPR2020-01053, No. 1039-39 Exhibit - EX 1039, Olanzapine 2001 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1039-39 Exhibit - EX 1039, Olanzapine 2001 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1013-13 Exhibit - EX 1013 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1013-13 Exhibit - EX 1013 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1004-4 Exhibit - EX 1004, Priority Application (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1004-4 Exhibit - EX 1004, Priority Application (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1019-19 Exhibit - EX 1019, US Patent No 9,174,975 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1019-19 Exhibit - EX 1019, US Patent No 9,174,975 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1029-29 Exhibit - EX 1029 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1029-29 Exhibit - EX 1029 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1010-10 Exhibit - EX 1010, Preliminary Amendment in Priority Application Feb 18, 2005 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1010-10 Exhibit - EX 1010, Preliminary Amendment in Priority Application Feb 18, 2005 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1016-16 Exhibit - EX 1016 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1016-16 Exhibit - EX 1016 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1003-3 Exhibit - EX 1003, The 827 Patent Application (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1003-3 Exhibit - EX 1003, The 827 Patent Application (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1046-44 Exhibit - EX 1046, File History from PAIR for the 827 Patent Application (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1046-44 Exhibit - EX 1046, File History from PAIR for the 827 Patent Application (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1022-22 Exhibit - EX 1022, DSM IV (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1022-22 Exhibit - EX 1022, DSM IV (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1020-20 Exhibit - EX 1020 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1020-20 Exhibit - EX 1020 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1031-31 Exhibit - EX 1031, Federal Register Dose Optimization Guidelines 1994 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1031-31 Exhibit - EX 1031, Federal Register Dose Optimization Guidelines 1994 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1023-23 Exhibit - EX 1023, DSM IV TR (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1023-23 Exhibit - EX 1023, DSM IV TR (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1011-11 Exhibit - EX 1011 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1011-11 Exhibit - EX 1011 (P.T.A.B. Jun. 5, 2020)
+ More Snippets
Document
IPR2020-01053, No. 1024-24 Exhibit - EX 1024, DSM 5 (P.T.A.B. Jun. 5, 2020)
Cite Document
IPR2020-01053, No. 1024-24 Exhibit - EX 1024, DSM 5 (P.T.A.B. Jun. 5, 2020)
+ More Snippets